Contact: Amanda Nelson

LEXINGTON, Ky. (Feb. 22, 2005)

WHAT: University of Kentucky ’s Dr. Leslie J. Crofford, a nationally recognized expert, will comment on COX-2 inhibitors (such as Celebrex, Bextra and Vioxx), in light of recent FDA meetings.

WHEN/WHERE: To arrange an interview at UK, news media may contact Amanda W. Nelson at (859) 323-6363.